Nicolas Anfossi
Affiliations: | Immunology Centre of Marseille-Luminy (CIML) |
Google:
"Nicolas Anfossi"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Cognet C, Farnarier C, Gauthier L, et al. (2010) Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells. Clinical Immunology (Orlando, Fla.). 135: 26-32 |
Romagné F, André P, Spee P, et al. (2009) Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells. Blood. 114: 2667-77 |
Anfossi N, André P, Guia S, et al. (2006) Human NK cell education by inhibitory receptors for MHC class I. Immunity. 25: 331-42 |
Anfossi N, Doisne JM, Peyrat MA, et al. (2004) Coordinated expression of Ig-like inhibitory MHC class I receptors and acquisition of cytotoxic function in human CD8+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 173: 7223-9 |
Anfossi N, Robbins SH, Ugolini S, et al. (2004) Expansion and function of CD8+ T cells expressing Ly49 inhibitory receptors specific for MHC class I molecules. Journal of Immunology (Baltimore, Md. : 1950). 173: 3773-82 |
André P, Castriconi R, Espéli M, et al. (2004) Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors. European Journal of Immunology. 34: 961-71 |
Vivier E, Anfossi N. (2004) Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nature Reviews. Immunology. 4: 190-8 |
Anfossi N, Lucas M, Diefenbach A, et al. (2003) Contrasting roles of DAP10 and KARAP/DAP12 signaling adaptors in activation of the RBL-2H3 leukemic mast cell line European Journal of Immunology. 33: 3514-3522 |